c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers.

被引：0
|
作者：
Tsuta, K. [1 ]
Yoshida, A. [1 ]
Tsuda, H. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1812
引用
收藏
页码：426A / 426A
页数：1
相关论文
共 50 条
  • [41] Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
    Fang, Mei-yu
    Xu, Chun-wei
    Wang, Wen-xian
    Wu, Mei-juan
    Zhuang, Wu
    Lin, Gen
    Chen, Xiao-hui
    Zhu, You-cai
    Liao, Xing-hui
    Du, Kal-qi
    Huang, Yun-jian
    Xu, Hai-peng
    Chen, Yan-ping
    Chen, Gang
    Lv, Tangfeng
    Song, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Metronomic weekly paclitaxel in metastatic or recurrent non-small cell lung cancers.
    Tandon, Nidhi
    Noronha, Vanita
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Prevalence of MET amplification, MET expression, and MET-related genomic alterations in non-small cell lung cancer (NSCLC)
    Ang, A. L.
    Yang, H.
    Anderson, A. A.
    Tang, R.
    Damore, M. A.
    Loberg, R. D.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 161 - 162
  • [44] Priming PD-L1 expression by chemotherapeutic agents in non-small cell lung cancers.
    Lin, Emily Pei-Ying
    Yang, Ching-Yao
    Lin, Ching-Wen
    Huang, Bo-Tsang
    Lai, Wei-Yun
    Tseng, Yi-Ting
    Yang, Pan-Chyr
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
    LP Stabile
    JS Lyker
    L Huang
    JM Siegfried
    Gene Therapy, 2004, 11 : 325 - 335
  • [46] Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy
    Stabile, LP
    Lyker, JS
    Huang, L
    Siegfried, JM
    GENE THERAPY, 2004, 11 (03) : 325 - 335
  • [47] c-Met expression and response to telisotuzumab vedotin (teliso-v) in patients with non-small cell lung cancer.
    Heist, Rebecca Suk
    Motwani, Monica
    Barlesi, Fabrice
    Goldman, Jonathan Wade
    Kelly, Karen
    Sun, Yan
    Wu, Jun
    Bach, Bruce Allen
    Camidge, D. Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Expression profiles of EGFR, c-Met, and mTOR/Wnt alternative signaling pathway proteins in non-small cell lung cancer
    Shearrow, Caleb
    Crees, Zachary
    Girard, Jennifer
    Harrington, Kymberly
    Arasi, Kavin
    Bertram, Ceyda
    Nowak, Andrew
    Lin, Leo
    Sheu, Bonnie
    Palani, Sunil
    Puri, Neelu
    CANCER RESEARCH, 2015, 75
  • [49] Unveiling the Role of HGF/c-Met Signaling in Non-Small Cell Lung Cancer Tumor Microenvironment
    Yao, Shuxi
    Liu, Xinyue
    Feng, Yanqi
    Li, Yiming
    Xiao, Xiangtian
    Han, Yuelin
    Xia, Shu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [50] METRIX: International real-world study of c-Met protein overexpression in patients with non-small cell lung cancer
    Horinouchi, H.
    Xu, Z.
    Prince, S. Savic
    De la Iglesia, P.
    Enrico, D. H.
    Desmeules, P.
    Koslucher, A.
    Ansell, P. J.
    Thiebaut, R.
    Hader, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S1643 - S1644
12345